Try our beta test site

Efficacy and Safety of Imatinib in Chordoma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
ClinicalTrials.gov Identifier:
NCT00150072
First received: September 7, 2005
Last updated: February 21, 2017
Last verified: February 2017